CEO Kevin Gerard Burke sells 27,000 DGICA shares ($535.5K) at $19.83, reducing stake by 69.8% to 11.7K shares
Kevin Gerard Burke, President & Chief Executive Officer of Donegal Group Inc, executed a material open-market sale of 27,000 shares (representing 69.8% of his pre-transaction holdings) for $535.5K at $19.83 on May 12, 2025. At the current price of $19.78, the transaction is just 1.1% below the 52-week high of $20.00, and the stock has appreciated 10.0% over the 30-day period and 31.3% over the 90-day period preceding the sale. Reviewing Burke's prior trades at this same ticker, his two previous sales (December 6, 2024 at 90-day return +7.9% and June 14, 2023 at 90-day return -7.2%) show mixed post-sale performance, with only one of the two prior sales occurring near a local peak. The substantial reduction in his personal stake—from 38.7K shares to 11.7K shares—represents a significant shift in ownership concentration and should be monitored in the context of the company's solid fundamentals (annual revenue growth of +6.7% and $25.2M net income on $245.2M revenue).
CEO KEVIN GERARD BURKE sells 90,000 shares (89.4% of holdings) at $16.67 on 2024-12-06 for $1.5M; prior sell at DGICA well-timed (90d -7.2%)
CEO Kevin Gerard Burke executed a substantial sale of 90,000 shares at $16.67, reducing his holdings by 89.4% from 100,710 to 10,710 shares. This represents a meaningful liquidation of his position in Donegal Group, reducing his direct stake nearly to single-digit percentages. His prior open-market sale activity shows a track record of well-timed exits (100.00% well-timed rate across all tickers), and specifically at DGICA he achieved a -7.2% return in the 90 days following his June 2023 sale, consistent with selling before declines. The current price of $16.35 remains within the 52-week range (trading 2.6% below the 52-week high of $16.78) and the company reports strong fundamentals with annual revenue growth of 9.3% and net income of $16.8M on $251.7M in quarterly revenue. The substantial reduction in CEO stake merits investor attention given the historical pattern of his sales preceding price weakness, though the company's operational metrics remain solid.
